Pembrolizumab in Combination With Olaparib in Advanced BRCA-mutated or HDR-defect Breast Cancer (opens ClinicalTrials.gov)
- Sponsor
- Yuan Yuan
- Enrolment
- 14
- Started
- 2017-09-10
- Last update
- 2026-10-28
Conditions: Breast Cancer
Interventions: Pembrolizumab, Olaparib